Miura Global Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Miura Global Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$2,226,140
+12.4%
14,0000.0%1.52%
+115.0%
Q2 2023$1,980,440
-74.4%
14,000
-69.6%
0.71%
-84.3%
Q1 2023$7,744,560
+69.4%
46,000
+70.4%
4.50%
+95.7%
Q4 2022$4,571,370
-54.6%
27,000
-49.8%
2.30%
-61.9%
Q3 2022$10,067,000
-58.3%
53,800
-63.8%
6.03%
-63.5%
Q2 2022$24,116,000
+32.5%
148,500
+53.4%
16.54%
+179.7%
Q1 2022$18,207,000
-23.6%
96,800
+7.6%
5.92%
+46.4%
Q4 2021$23,836,000
-3.0%
90,000
+5.9%
4.04%
+6.1%
Q3 2021$24,564,000
+48.4%
85,000
+2.5%
3.81%
+26.1%
Q2 2021$16,548,000
+52.0%
82,900
+48.0%
3.02%
+55.3%
Q1 2021$10,887,000
+31.2%
56,000
+29.3%
1.94%
+24.1%
Q4 2020$8,298,000
+37.8%
43,300
+6.1%
1.57%
-8.2%
Q3 2020$6,020,000
-27.3%
40,800
-39.1%
1.71%
-21.9%
Q2 2020$8,282,000
+14.4%
67,000
-10.7%
2.19%
+16.6%
Q1 2020$7,241,000
-31.9%
75,000
-34.8%
1.88%
+2.5%
Q4 2019$10,638,000
-7.5%
115,000
-23.3%
1.83%
-9.7%
Q3 2019$11,504,000
-23.5%
150,000
-14.3%
2.02%
-16.8%
Q2 2019$15,041,000
+185.2%
175,000
+75.0%
2.44%
+81.0%
Q4 2018$5,274,000
-65.4%
100,000
-63.6%
1.34%
-52.2%
Q3 2018$15,252,000
+159.4%
275,000
+120.0%
2.81%
+102.5%
Q2 2018$5,880,000125,0001.39%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders